The Dallas Mavericks left Salt Lake City with more than a narrow loss on their minds. Thursday night’s 116-114 defeat to the Utah Jazzended with Anthony Davis heading to the locker room early, holding his left hand and leaving the bench visibly concerned. What initially looked like a routine in-game injury quickly turned into something much heavier.
For Dallas, the timing could not be more uncomfortable. The team has been walking a fine line between competing now and keeping options open ahead of February’s trade deadline. Davis has been central to both conversations. His presence on the floor anchors the Mavericks, and his name has hovered in league-wide speculation for weeks.
Anthony Davis was dunking hard hours before getting injured once again
By Friday morning, the picture sharpened. ESPN insider Shams Charania reported that Anthony Davis suffered ligament damage in his left hand, according to league sources. The update immediately shifted focus from short-term pain management to long-term availability. Depending on the outcome of a second opinion and whether surgery is required, Davis could miss several months.
That possibility changes everything. Teams exploring trade scenarios typically look for clarity, not medical uncertainty. At 32, Davis remains a high-impact player, but an extended absence would naturally make front offices pause. Even without surgery, ligament injuries in the hand often demand cautious timelines, especially for big men who rely on strength, touch, and constant contact.
“The Mavericks will seek a hand specialist’s opinion on the extent of the damage to Anthony Davis’ left hand, but league sources confirm tonight that their fears of ligament damage from the injury sustained in Utah appear to have been validated. Davis is out for an unknown period.
Marc Stein
What this means for Dallas and the deadline
NBA reporter Marc Stein added further context later in the day, noting that the Mavericks plan to consult a hand specialist. League sources confirmed that initial fears of ligament damage appear to have been justified, leaving Davis sidelined for an undefined period.
For Dallas, the lack of a clear return date complicates planning. If surgery becomes necessary, a trade is still possible, but the value equation shifts. A team taking on Davis would be betting on recovery rather than immediate production. That kind of gamble tends to narrow the field of interested buyers.
From a league perspective, this is a familiar but unforgiving scenario. Hand ligament injuries often require patience and careful rehab, with setbacks not uncommon. For the Mavericks, that reality adds pressure as the calendar moves closer to key decision points.
Right now, the focus stays on evaluations and next steps. Anthony Davis’ timeline remains uncertain, and so does Dallas’ path forward. Until more information emerges, both the Mavericks and the NBA trade market are left waiting.









